Primary Peritoneal Carcinoma Completed Phase 1 Trials for Propranolol (DB00571)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01308944Therapeutic Targeting of Stress Factors in Ovarian Cancer PatientsTreatment